Javier Fernández-Ruiz (Javier Fernandez-Ruiz)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Topics

Replacement Therapy

Amyotrophic Lateral Sclerosis

Lower Urinary Tract Symptoms

Cerebral Ischemia

Top Venues

British journal of pharmacology

Journal of neuroinflammation

Molecules (Basel, Switzerland)

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology 181 (6) (2024)
Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology 181 (6) (2024)
Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology 181 (6) (2024)
Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology (2024)
Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology 181 (6) (2024)
Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli, María Angeles Moro
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. British journal of pharmacology 181 (6) (2024)
Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice. Journal of neuroinflammation 20 (1) (2023)
Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice. Journal of neuroinflammation 20 (1) (2023)
Irene Santos-García, Carmen Rodríguez-Cueto, Patricia Villegas, Fabiana Piscitelli, Anna Lauritano, Che-Kun J Shen, Vincenzo Di Marzo, Javier Fernández-Ruiz, Eva de Lago
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice. Journal of neuroinflammation 20 (1) (2023)
Santiago Rodríguez-Carreiro, Elisa Navarro, Eduardo Muñoz, Javier Fernández-Ruiz
The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy. Brain sciences 13 (9) (2023)
Isabel Lastres-Becker, Eva de Lago, Ana Martinez, Javier Fernández-Ruiz
New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Biomolecules 12 (9) (2022)
Laura Figuerola-Asencio, Paula Morales, Pingwei Zhao, Dow P Hurst, Sommayah S Sayed, Katsuya L Colón, María Gómez-Cañas, Javier Fernández-Ruiz, Mitchell P Croatt, Patricia H Reggio, Mary E Abood, Nadine Jagerovic
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship. ACS medicinal chemistry letters 14 (1) (2022)
Laura Figuerola-Asencio, Paula Morales, Pingwei Zhao, Dow P Hurst, Sommayah S Sayed, Katsuya L Colón, María Gómez-Cañas, Javier Fernández-Ruiz, Mitchell P Croatt, Patricia H Reggio, Mary E Abood, Nadine Jagerovic
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship. ACS medicinal chemistry letters 14 (1) (2022)
Marta Gómez-Almería, Sonia Burgaz, Carlos Costas-Insua, Carmen Rodríguez-Cueto, Irene Santos-García, Ignacio Rodríguez-Crespo, Concepción García, Manuel Guzmán, Eva de Lago, Javier Fernández-Ruiz
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis. International journal of molecular sciences 22 (22) (2021)
Sonia Burgaz, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, Carmen Rodríguez-Cueto, Eva de Lago, Eduardo Muñoz, Javier Fernández-Ruiz
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis. Molecules (Basel, Switzerland) 26 (24) (2021)
Carmen Rodríguez-Cueto, Laura García-Toscano, Irene Santos-García, Marta Gómez-Almería, Claudia Gonzalo-Consuegra, Francisco Espejo-Porras, Javier Fernández-Ruiz, Eva de Lago
Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis. British journal of pharmacology 178 (6) (2021)
Sonia Burgaz, Concepción García, María Gómez-Cañas, Alain Rolland, Eduardo Muñoz, Javier Fernández-Ruiz
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease. Molecules (Basel, Switzerland) 26 (11) (2021)
Carmen Rodríguez-Cueto, Marta Gómez-Almería, Laura García Toscano, Julián Romero, Cecilia J Hillard, Eva de Lago, Javier Fernández-Ruiz
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis. Brain pathology (Zurich, Switzerland) 31 (6) (2021)
Belén Palomares, Martín Garrido-Rodriguez, Claudia Gonzalo-Consuegra, María Gómez-Cañas, Suwipa Saen-Oon, Robert Soliva, Juan A Collado, Javier Fernández-Ruiz, Gaetano Morello, Marco A Calzado, Giovanni Appendino, Eduardo Muñoz
Δ9 -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors. British journal of pharmacology 177 (17) (2020)
Paula Morales, Gemma Navarro, Marc Gómez-Autet, Laura Redondo, Javier Fernández-Ruiz, Laura Perez Benito, Arnau Cordomi, Leonardo Pardo, Rafael Franco, Nadine Jagerovic
Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor*. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (68) (2020)
Sonia Burgaz, Concepción García, Maria Gómez-Cañas, Eduardo Muñoz, Javier Fernández-Ruiz
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease. Molecules (Basel, Switzerland) 24 (15) (2019)
Francisco Espejo-Porras, Laura García-Toscano, Carmen Rodríguez-Cueto, Irene Santos-García, Eva de Lago, Javier Fernández-Ruiz
Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis. British journal of pharmacology 176 (10) (2018)
Carmen Del Rio, Irene Cantarero, Belén Palomares, María Gómez-Cañas, Javier Fernández-Ruiz, Carolina Pavicic, Adela García-Martín, Maria Luz Bellido, Rafaela Ortega-Castro, Carlos Pérez-Sánchez, Chary López-Pedrera, Giovanni Appendino, Marco A Calzado, Eduardo Muñoz
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways. British journal of pharmacology 175 (19) (2018)
Javier Fernández-Ruiz
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes. British journal of pharmacology 176 (10) (2018)
Francisco Espejo-Porras, Javier Fernández-Ruiz, Eva de Lago
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients. Amyotrophic lateral sclerosis & frontotemporal degeneration 19 (5-6) (2018)
Carmen Rodríguez-Cueto, Mariluz Hernández-Gálvez, Cecilia J Hillard, Patricia Maciel, Sara Valdeolivas, José A Ramos, María Gómez-Ruiz, Javier Fernández-Ruiz
Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3. PloS one 12 (4) (2017)